Walgreens and The US Mass Beauty Market
Former SVP of Consumer Beauty at Coty and Group VP of Beauty at Walgreens
inpractise.com/articles/us-mass-beauty-market
Why is this interview interesting?
- The importance of the ‘gross to net’ calculation between manufacturer and retailer
- How a beauty retailer optimizes shelf space and profitability
- Why mass retailers are cutting shelf space for international brands and increasing private label
- Decision-making process for drugstores choosing indie brands
- How marketing students can improve the chance of working in the beauty industry
Walgreens and The US Mass Beauty Market(October 2, 2019)
Shannon Curtin
Former SVP of Consumer Beauty at Coty and Group VP of Beauty at Walgreens
Shannon has over 15 years' experience in the retail industry starting in 2000 rotating through various merchandising positions at Walmart. Shannon then moved to Walgreens in 2009 where she was responsible for $7.5B in P&L and over 12,000 SKUs across 8200 stores as Group Vice President/General Merchandise Manager Beauty/Personal Care. She then left for Coty in 2015 and was GM, USA & SVP North America, Consumer Beauty for two years before leaving to work with young cosmetic and beauty businesses.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Related Content
Walgreens: Marketing Private Label Cosmetics
Former SVP of Consumer Beauty at Coty and Group VP of Beauty at Walgreens
Walgreens: How a Beauty Buyer Operates
Former SVP of Consumer Beauty at Coty and Group VP of Beauty at Walgreens
Walgreens: Beauty Private Label Growth
Former SVP of Consumer Beauty at Coty and Group VP of Beauty at Walgreens
Buying & Merchandising: Importance of Understanding Finance
Former SVP of Consumer Beauty at Coty and Group VP of Beauty at Walgreens
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2023 IP 1 Ltd. All rights reserved.